Archives

Meet the Insurer Making Money From ObamaCare

September 28, 2016

A California-based insurer that once sold mostly Medicaid plans has become a top competitor in ObamaCare’s marketplaces.In likely the toughest year yet for the reform law, Molina Healthcare is thriving in a market that’s seen high-profile departures from some of the nation’s largest health insurers. Read More

Would you Like Some Insurance With Your Insurance?

September 28, 2016

Gap insurance is in a category of insurance known as “limited benefit.” No matter how bad a person’s situation, the plan will pay out only a certain amount of money. “Mini-med” policies, now illegal under the Affordable Care Act, are another example of a limited benefit plan. Read More

Tobacco Tax Ballot Measure Would Fund Health Care For California’s Poor – But How?

September 28, 2016

At first blush, the tobacco tax measure on California’s November ballot looks pretty straightforward. Proposition 56 would raise the price of a pack of cigarettes by $2 and tax e-cigarettes for the first time. Proponents say the higher price would prevent kids from smoking and lower health care spending because people won’t suffer as much from tobacco-related illness. Read More

Brown Signs Raft of New Health Laws

September 28, 2016

California consumers will have the strongest protections in the nation against getting blindsided by unexpected out-of-network medical bills as part of legislation signed into law by Gov. Jerry Brown. Read More

CaliforniaChoice Adds Two New Plans For Small Businesses

September 28, 2016

CHOICE Administrators announced today the addition of two popular Western Health Advantage health plans to its coverage options for Northern California groups enrolling in CaliforniaChoice. The private health exchange, which marked its 20th anniversary earlier this year, is now quoting GOLD HMO C (Gateway 4010) and GOLD HMO D (Gateway 200 HSA) for groups of two to 100 employees for coverage effective December 1, 201 Read More

Even Generic-Drug Prices Are Going Through the Roof

September 20, 2016

The good news: U.S. consumers still get more bang for their buck from generic drugs as prices of the cheaper versions of the originals are generally falling. The bad news: Recent years have seen an increasing count of sharp cost spikes for generics -- the drugs produced after the patents on their branded versions expire. Read More